Somewhere along the line, Fred Eisenrich, 78, lost count of the number of cancerous tumors surgeons removed from his body. But he does remember the last time they had to cut him open.

“That time, they took 10 tumors out of my small intestine,” he said.

Double-digit tumor removal later, Eisenrich is classified as cancer-free and in remission, living in retirement from his job at PNC bank.

“I rang the bell in 2018,” he said, referring to the bell that patients ring in the cancer ward once they have a clear scan and are considered in remission.

Advertise with us

He’s grateful to the physicians who saved his life and to the immunotherapy drugs that worked like a charm to clear his body of cancer. So to give back, he’s sharing his poop.

It's part of an emerging approach, pioneered by doctor-researchers at the UPMC Hillman Cancer Center, in which fecal matter transplants introduce favorable microorganisms. The aim is to bolster patients' gut microbiomes to better prepare their bodies to respond to immunotherapy medications. And the results to date are promising.

With cancer killing more than half a million people a year in the United States, there’s almost no boundary too wild to consider if it might improve cancer survival. Here in the Steel City, behind the walls of UPMC Hillman, Drs. Diwakar Davar and Hassane Zarour have a refrigerator full of excrement to prove it.

Diwakar Davar, left, at the UPMC Hillman Cancer Center lab, with clinical research coordinator Drew Hurd. (UPMC)

While immunotherapy — using a patient’s own immune system to fight disease — can be dated back centuries, immunotherapy treatment as we know it today was only relatively recently approved for cancer patients. But it’s not perfect.

“Thirty to 40% of patients are going to respond [to immunotherapy],” said Zarour, “but the majority are not going to respond.”

Advertise with us

Steve Piskurich, 62, and a native of Pittsburgh, is one of those non-responders. After a few rounds of immunotherapy, including prescription medication Keytruda, to treat melanoma in 2018, one tenacious tumor kept growing back in his chest.

So the doctors turned to “the bugs” in his poop.

Roiling around in our digestive system are trillions of microorganisms — the bugs, as Zarour calls them — that have co-evolved with humans over thousands of years.

Hassane Zarour with a frozen sample in the lab. (UPMC)

We rely on these various viruses, bacteria and fungi to stay healthy. In fact, the microorganisms altogether essentially function as an organ in the body, helping digest foods and fiber, potentially coordinating neurologic responses with our brains, and, crucially to Davar and Zarour, encouraging the immune system response to infections and disease.

Perhaps, the doctors thought, Piskurich didn’t have the right gut microbiome — the right combination of bugs.

Advertise with us

“If you don’t have favorable microorganisms, you don’t respond,” said Davar, “If you have favorable microorganisms, you tend to do a little better.”

To remedy Piskurich’s unfavorable microbiome, Davar recommended he enroll in a trial to receive a stool sample from a healthy donor — someone like Eisenrich.

The fecal matter transplant is pretty straightforward. Donors have collected their poop either at home or in Shadyside’s UPMC Hillman facility and given it to the researchers. Then it is tested to make sure it’s safe before being stored in a giant refrigerator.

The recipient receives the donation through a colonoscopy to upgrade their gut biota. The procedure is repeated while the patient undergoes immunotherapy treatment, and the hope is their new microbiome stimulates the immune system to fight the cancer.

Doing these transplants, Davar and Zarour have seen early success in the trials that they’ve published. Davar believes that adding fecal matter transplants to immunotherapy could add “10 to 15%” to the number of people who respond well.

Advertise with us

That might not seem like a huge number, but to Davar, it’s significant.

“If you think about it, we spend billions of dollars on developing drugs to get to 5%,” he said. “This could be a really simple, easy, relatively cost-effective solution that gets you to 10%.”

Behind those percentages are real people like Piskurich, who credits his doctors with an innovation that truly saved his life. He rang the UPMC cancer-free bell in 2021, something he feared he’d never get to do.

Steve Piskurich with his wife, Janice Kish, on vacation the year after he rang the cancer-free bell. (Courtesy of Steve Piskurich)

Indeed, people are coming from all over to get some Pittsburgh poop.

“We’ve had referrals from people in Baltimore at Johns Hopkins,” said Davar. “They’re sending us patients because they believe in what we’re doing.”

Advertise with us

Now, Davar and Zarour are looking to the future. They believe that checking a patient’s gut microbiome may eventually become as standard as a mammogram or prostate check to prevent cancer and catch it early.

Eventually, they hope to isolate the specific microbiome that makes a patient like Eisenrich respond well to immunotherapy so that they can predict patient response before treatment.

Perhaps soon, instead of undergoing the fecal transplants, cancer patients will be able to take a pill with the right cocktail of microorganisms to ensure that more patients ring the cancer-free bells than ever before.

Anna Marie Zorn (amzorn@gmail.com) is a science communicator and freelance writer based in Milwaukee, Wisconsin.

Correction: An earlier version of this story incorrectly identified the facility where the research is being done. It is the UPMC Hillman Cancer Center.